(Q77771171)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Antithrombotic effect of SM-20302, a nonpeptide GPIIb/IIIa antagonist, in a photochemically induced thrombosis model in guinea pigs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

S Horisawa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

M Kaneko

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Y Ikeda

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Y Ueki

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

T Sakurama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

227-234

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

Platelet activation in clinical coronary artery disease and spasm

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Role of platelets and thrombosis in coronary atherosclerotic disease and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Platelet activation in unstable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp--specific adhesion receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

In vivo efficacy of SM-20302, a GP IIb/IIIa receptor antagonist, correlates with ex vivo platelet inhibition in heparinized blood but not in citrated blood

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Pharmacokinetics and pharmacodynamics of SM-20302, a GPIIb/IIIa receptor antagonist, in anesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

TP-9201, a glycoprotein IIb/IIIa platelet receptor antagonist, prevents rethrombosis after successful arterial thrombolysis in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Photochemically induced thrombosis model in rat femoral artery and evaluation of effects of heparin and tissue-type plasminogen activator with use of this model

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

SC-54684A: an orally active inhibitor of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Profound and sustained inhibition of platelet aggregation by Fradafiban, a nonpeptide platelet glycoprotein IIb/IIIa antagonist, and its orally active prodrug, Lefradafiban, in men

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Effects of ticlopidine and indobufen on platelet aggregation induced by A23187 and adrenaline in the presence of different anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Early clinical experience with integrelin, an inhibitor of the platelet glycoprotein IIb/IIIa integrin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

Effects of Integrelin on platelet function in flow models of arterial thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2898%2900215-1

7 January 2021

10.1016/S0049-3848(98)00215-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10336238%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference